Royalty Pharma plc (RPRX)
USD 29.97
(-3.66%)
USD 29.97
(-3.66%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 862.4 Million USD | -34.38% |
| 2022 | 1.31 Billion USD | 53.05% |
| 2021 | 858.74 Million USD | 62.95% |
| 2020 | 527 Million USD | 165.15% |
| 2019 | -808.92 Million USD | -287.93% |
| 2018 | 430.44 Million USD | -34.61% |
| 2017 | 658.23 Million USD | -39.41% |
| 2016 | 1.08 Billion USD | 37.51% |
| 2015 | 789.98 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 641.75 Million USD | 3875.01% |
| 2024 Q2 | 267.63 Million USD | -58.3% |
| 2023 Q1 | 204.99 Million USD | -52.61% |
| 2023 Q4 | -17 Million USD | -104.42% |
| 2023 Q2 | 289.36 Million USD | 41.15% |
| 2023 FY | 862.4 Million USD | -34.38% |
| 2023 Q3 | 384.87 Million USD | 33.01% |
| 2022 FY | 1.31 Billion USD | 53.05% |
| 2022 Q4 | 432.57 Million USD | 13.46% |
| 2022 Q3 | 381.25 Million USD | 141.05% |
| 2022 Q2 | 158.16 Million USD | -53.8% |
| 2022 Q1 | 342.33 Million USD | -18.93% |
| 2021 Q3 | 282.72 Million USD | 248.81% |
| 2021 Q4 | 422.28 Million USD | 49.36% |
| 2021 Q1 | 343.73 Million USD | 33.23% |
| 2021 FY | 858.74 Million USD | 62.95% |
| 2021 Q2 | -189.98 Million USD | -155.27% |
| 2020 Q3 | 28 Million USD | -72.44% |
| 2020 Q1 | 139.44 Million USD | 115.95% |
| 2020 FY | 527 Million USD | 165.15% |
| 2020 Q4 | 258 Million USD | 821.43% |
| 2020 Q2 | 101.58 Million USD | -27.15% |
| 2019 Q1 | 3.98 Million USD | 0.0% |
| 2019 FY | -808.92 Million USD | -287.93% |
| 2019 Q4 | -874.43 Million USD | -1181.77% |
| 2019 Q3 | -68.22 Million USD | -152.58% |
| 2019 Q2 | 129.74 Million USD | 3157.57% |
| 2018 FY | 430.44 Million USD | -34.61% |
| 2017 FY | 658.23 Million USD | -39.41% |
| 2016 FY | 1.08 Billion USD | 37.51% |
| 2015 FY | 789.98 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -213.337% |
| Alkermes plc | 996.24 Million USD | 13.435% |
| Agenus Inc. | 78.18 Million USD | -1003.058% |
| Aptorum Group Limited | 10.56 Thousand USD | -8161967.007% |
| Ardelyx, Inc. | 169.93 Million USD | -407.485% |
| Dyadic International, Inc. | 9.15 Million USD | -9322.404% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -3775.451% |
| Lantern Pharma Inc. | 17.87 Million USD | -4723.944% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -12710.623% |
| Novavax, Inc. | 779.12 Million USD | -10.689% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -963.882% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -949.204% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -4341.143% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2812.937% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1523.306% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -126.653% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3448.023% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -2177.335% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2702.652% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -917.994% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -4840.162% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -412.007% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -2536.112% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -439.721% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 52.09% |
| AlloVir, Inc. | 180.93 Million USD | -376.643% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -93.478% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2805.478% |
| Bicycle Therapeutics plc | 216.92 Million USD | -297.564% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -401.684% |
| ChromaDex Corporation | 56.37 Million USD | -1429.655% |
| Chimerix, Inc. | 93.38 Million USD | -823.454% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -6100.045% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -472.889% |
| CRISPR Therapeutics AG | 463.49 Million USD | -86.066% |
| Precision BioSciences, Inc. | 92.46 Million USD | -832.702% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -239.47% |
| Fortress Biotech, Inc. | 200.19 Million USD | -330.782% |
| Fortress Biotech, Inc. | 200.19 Million USD | -330.782% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -2533.616% |
| ImmuCell Corporation | 9.61 Million USD | -8867.158% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -446.469% |
| Immix Biopharma, Inc. | 16.14 Million USD | -5242.903% |
| Incyte Corporation | 1.19 Billion USD | 27.559% |
| Innoviva, Inc. | 132.15 Million USD | -552.575% |
| IO Biotech, Inc. | 91.44 Million USD | -843.106% |
| Jaguar Health, Inc. | 42.01 Million USD | -1952.61% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -409.463% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -922.739% |
| ContextLogic Inc. | 387 Million USD | -122.843% |
| MiMedx Group, Inc. | 229.72 Million USD | -275.404% |
| MEI Pharma, Inc. | 34.78 Million USD | -2379.241% |
| NextCure, Inc. | 67.63 Million USD | -1175.048% |
| Onconetix, Inc. | 34.9 Million USD | -2370.546% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -6666.076% |
| Opthea Limited | 191.96 Million USD | -349.245% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -31242.081% |
| Vaxcyte, Inc. | 468.04 Million USD | -84.258% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1903.483% |
| Precigen, Inc. | 84.18 Million USD | -924.464% |
| Pharming Group N.V. | 225.49 Million USD | -282.456% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -413.865% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -1088.441% |
| PureTech Health plc | 144.59 Million USD | -496.419% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -562.048% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -251.775% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3448.023% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -277.123% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2694.66% |
| Acelyrin, Inc. | 422.06 Million USD | -104.33% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -6688313.215% |
| Summit Therapeutics Inc. | 87.68 Million USD | -883.514% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -2226.797% |
| Senti Biosciences, Inc. | 94.7 Million USD | -810.621% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -598.003% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1797.687% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2826.479% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -21777.055% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -552.471% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -2430.157% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -10104.757% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -375.675% |
| Seer, Inc. | 110.49 Million USD | -680.527% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -1121.639% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -822.574% |
| ESSA Pharma Inc. | 32.13 Million USD | -2583.766% |
| GlycoMimetics, Inc. | 39.28 Million USD | -2095.234% |
| GT Biopharma, Inc. | 13.57 Million USD | -6252.416% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -292.305% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -328.811% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -232.429% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1419.414% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1494.682% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -8578.153% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -113.697% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -4455.993% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -1601.229% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -232.129% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1547.192% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -5884.605% |
| Soligenix, Inc. | 7.79 Million USD | -10963.197% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1438.057% |
| Kura Oncology, Inc. | 165.8 Million USD | -420.135% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -653.145% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -10266.679% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -34651.388% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -700.761% |
| Autolus Therapeutics plc | 196.72 Million USD | -338.378% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -918.704% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -640.56% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -4349.28% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -168.029% |
| GRI Bio, Inc. | 11.33 Million USD | -7511.686% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -12122.797% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -557.355% |
| IGM Biosciences, Inc. | 265.59 Million USD | -224.711% |
| INmune Bio, Inc. | 29.89 Million USD | -2784.68% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -399.788% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2039.201% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -5296.987% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -5378.519% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -1288.779% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -702.072% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -212.813% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -186.084% |
| Verastem, Inc. | 92.08 Million USD | -836.541% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -4707.425% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -364.345% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -610.341% |
| Histogen Inc. | 14.27 Million USD | -5942.629% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -5273.856% |
| Surrozen, Inc. | 18.55 Million USD | -4549.078% |
| Organovo Holdings, Inc. | 14.91 Million USD | -5682.125% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -16842.319% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1345.213% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -3262.592% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1734.668% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -11198.595% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -384.127% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1680.063% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -251.996% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -5512.207% |
| Apollomics, Inc. | 54.14 Million USD | -1492.915% |
| Amarin Corporation plc | 272.35 Million USD | -216.645% |
| Mesoblast Limited | 5.9 Million USD | -14512.064% |
| Turnstone Biologics Corp. | 78.33 Million USD | -1000.876% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -253.268% |
| Synaptogenix, Inc. | 8.31 Million USD | -10273.095% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -5812.546% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -240.796% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -2487.465% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -9665.384% |
| Exelixis, Inc. | 1.58 Billion USD | 45.651% |
| Better Therapeutics, Inc. | 38.26 Million USD | -2153.944% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -271.646% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -0.842% |
| NLS Pharmaceutics AG | 11.8 Million USD | -7204.137% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -10623.876% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -2775.351% |
| Gritstone bio, Inc. | 148.37 Million USD | -481.237% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1152.384% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -5171.348% |
| Avid Bioservices, Inc. | 25.99 Million USD | -3217.449% |
| Insmed Incorporated | 949.26 Million USD | 9.15% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -5396.594% |
| MediWound Ltd. | 18.86 Million USD | -4470.723% |
| OmniAb, Inc. | 83.89 Million USD | -927.956% |
| Alector, Inc. | 248.8 Million USD | -246.623% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -268.064% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1550.502% |
| Zai Lab Limited | 547.47 Million USD | -57.524% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -116.329% |
| Aura Biosciences, Inc. | 84.99 Million USD | -914.7% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -248.956% |
| Immunic, Inc. | 99.22 Million USD | -769.157% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -442.352% |
| Veracyte, Inc. | 357.93 Million USD | -140.94% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 90.434% |
| FibroGen, Inc. | 398.11 Million USD | -116.623% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -5968.994% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -12420.48% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -12002.672% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 73.51% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -3233.22% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -172.445% |
| TG Therapeutics, Inc. | 198.47 Million USD | -334.515% |
| Galecto, Inc. | 35.62 Million USD | -2320.647% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -2019.502% |
| Fortrea Holdings Inc. | 457.3 Million USD | -88.586% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1488.865% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -2886.37% |
| XBiotech Inc. | 37.51 Million USD | -2199.131% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1152.384% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -4076.493% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -507.066% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -770.456% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -678.933% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 10.002% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -2889.787% |
| Vaxxinity, Inc. | 56.05 Million USD | -1438.606% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -100.261% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -3765.841% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -677.873% |
| NexImmune, Inc. | 28.16 Million USD | -2961.698% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -15492.336% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -4719.916% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 69.367% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -3287.423% |
| Scopus BioPharma Inc. | 11.71 Million USD | -7261.614% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -578.727% |
| Ainos, Inc. | 12.95 Million USD | -6558.121% |
| Pluri Inc. | 22.48 Million USD | -3736.317% |
| Prothena Corporation plc | 282.4 Million USD | -205.377% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -331.155% |
| Celularity Inc. | 215.05 Million USD | -301.01% |
| Rallybio Corporation | 78.93 Million USD | -992.591% |
| Cue Biopharma, Inc. | 19.54 Million USD | -4313.08% |
| MeiraGTx Holdings plc | 151.07 Million USD | -470.834% |
| Omeros Corporation | 94.75 Million USD | -810.179% |
| Humacyte, Inc. | 23.49 Million USD | -3570.273% |
| Immunocore Holdings plc | 308.04 Million USD | -179.965% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -25339.646% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -892.81% |
| Blueprint Medicines Corporation | 722.86 Million USD | -19.304% |
| CalciMedica, Inc. | 21.81 Million USD | -3852.899% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1055.108% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -437.189% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -403.461% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -192.4% |
| Pulmatrix, Inc. | 22.03 Million USD | -3813.259% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -2394.299% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -870.454% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -56.356% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -1088.687% |
| Cytokinetics, Incorporated | 173.61 Million USD | -396.742% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -2405.604% |
| Nutriband Inc. | 5.73 Million USD | -14940.1% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1877.401% |
| Vor Biopharma Inc. | 126.03 Million USD | -584.252% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 27.479% |
| Evogene Ltd. | 27.79 Million USD | -3003.289% |
| ProKidney Corp. | 151.52 Million USD | -469.161% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1062.661% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -11111.348% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -40.405% |
| CorMedix Inc. | 48.95 Million USD | -1661.526% |
| BioLineRx Ltd. | 50.8 Million USD | -1597.579% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -472.265% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -2165.192% |
| Atai Life Sciences N.V. | 125.78 Million USD | -585.618% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -956.359% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -959.347% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -241.476% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -2534.099% |
| MediciNova, Inc. | 10.9 Million USD | -7811.771% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -569.464% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -11779.622% |
| GeoVax Labs, Inc. | 6.02 Million USD | -14220.479% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -81.04% |
| Biomea Fusion, Inc. | 126.13 Million USD | -583.715% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 34.26% |
| Mereo BioPharma Group plc | 35.84 Million USD | -2306.127% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -351.31% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -275.033% |
| Absci Corporation | 73.66 Million USD | -1070.695% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -3026.691% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -545.56% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -256.127% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -229.102% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -314.629% |
| Allakos Inc. | 196.05 Million USD | -339.876% |
| Imunon, Inc. | 20.31 Million USD | -4146.115% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -660.035% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -133.96% |
| BioAtla, Inc. | 129.68 Million USD | -564.989% |
| NLS Pharmaceutics AG | 11.8 Million USD | -7204.137% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -5343.439% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -915.573% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1965.243% |
| XOMA Corporation | 46.46 Million USD | -1756.109% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -675.745% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -505.353% |
| aTyr Pharma, Inc. | 12.97 Million USD | -6544.611% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -731.987% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -398.874% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -238.511% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -2205.4% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -10385.392% |
| Akari Therapeutics, Plc | 16.8 Million USD | -5031.524% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -37825.039% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -188.123% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -12716.743% |
| UroGen Pharma Ltd. | 138.88 Million USD | -520.935% |
| Sutro Biopharma, Inc. | 243 Million USD | -254.886% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -11754.966% |
| Orgenesis Inc. | 45.75 Million USD | -1784.748% |
| Entera Bio Ltd. | 8.86 Million USD | -9633.679% |
| GH Research PLC | 41.22 Million USD | -1992.096% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -3254.613% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -938.378% |
| Xencor, Inc. | 306.97 Million USD | -180.934% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -17380.196% |
| Replimune Group, Inc. | 234.77 Million USD | -267.335% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -4108.925% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -349.646% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -12716.743% |
| Portage Biotech Inc. | 18.19 Million USD | -4638.744% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -11779.622% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -721.642% |
| OncoCyte Corporation | 25.63 Million USD | -3263.904% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -14047.959% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -7427.271% |
| Purple Biotech Ltd. | -22.46 Million USD | 3938.537% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -5133.034% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1223.152% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -10102.661% |
| HilleVax, Inc. | 133.34 Million USD | -546.746% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -8285.066% |
| Tharimmune, Inc. | 9.45 Million USD | -9020.93% |
| Genprex, Inc. | 31.06 Million USD | -2676.524% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -359.885% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2648.523% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -112632.549% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -15732.877% |
| OKYO Pharma Limited | 8243.57 USD | -10461435.476% |
| Savara Inc. | 15.74 Million USD | -5377.32% |
| Curis, Inc. | 58.35 Million USD | -1377.858% |
| Daré Bioscience, Inc. | 33.6 Million USD | -2465.961% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -16834.826% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -11458.826% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -3091.488% |
| BeiGene, Ltd. | 3.28 Billion USD | 73.76% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -4225.147% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -72.908% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -461.271% |
| Erasca, Inc. | 141.52 Million USD | -509.365% |
| bluebird bio, Inc. | 240.23 Million USD | -258.988% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -18950.341% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 50.615% |
| DBV Technologies S.A. | 92.16 Million USD | -835.768% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -18950.341% |
| Moderna, Inc. | 6.39 Billion USD | 86.512% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1923.995% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -5903.091% |
| Molecular Templates, Inc. | 63.09 Million USD | -1266.921% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -1192.94% |
| Travere Therapeutics, Inc. | 472 Million USD | -82.712% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -501.771% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -1289.137% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1886.465% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -314.358% |
| MacroGenics, Inc. | 217.21 Million USD | -297.028% |
| RenovoRx, Inc. | 11.39 Million USD | -7467.603% |
| Adicet Bio, Inc. | 152.03 Million USD | -467.229% |
| Prime Medicine, Inc. | 186.63 Million USD | -362.071% |
| Aditxt, Inc. | 25.95 Million USD | -3223.232% |
| Adagene Inc. | 41.83 Million USD | -1961.621% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -11697.434% |
| Quantum-Si incorporated | 111.65 Million USD | -672.355% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -401.835% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -5815.885% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -2307.47% |
| SciSparc Ltd. | 9.01 Million USD | -9470.569% |
| Vericel Corporation | 142.04 Million USD | -507.156% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -9862.313% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -3635.195% |
| Generation Bio Co. | 144.46 Million USD | -496.956% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -938.666% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -897.46% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -191.629% |
| Invivyd, Inc. | 205.75 Million USD | -319.141% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -1095.144% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -9095.539% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1045.991% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -8283.435% |
| 2seventy bio, Inc. | 289.88 Million USD | -197.497% |
| ADMA Biologics, Inc. | 66.58 Million USD | -1195.173% |
| Clene Inc. | 41.07 Million USD | -1999.686% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -6633.383% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1473.845% |
| GeoVax Labs, Inc. | 6.02 Million USD | -14220.479% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -144.968% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -2247.826% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -2456.938% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -731.618% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -2546.304% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -406.468% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -12.333% |
| Evaxion Biotech A/S | 22.27 Million USD | -3772.492% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -536.254% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -267.165% |
| Trevena, Inc. | 38.41 Million USD | -2145.084% |
| Surrozen, Inc. | 18.55 Million USD | -4549.078% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -978.747% |
| Cingulate Inc. | 22.75 Million USD | -3689.256% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 11610.998% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1830.741% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -10373.769% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -740.894% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -14.364% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -1289.316% |
| Clearmind Medicine Inc. | 8.74 Million USD | -9765.799% |
| Kronos Bio, Inc. | 128.11 Million USD | -573.133% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -925.792% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -29303.628% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -755.33% |
| Statera Biopharma, Inc. | 28.82 Million USD | -2891.394% |
| ImmunityBio, Inc. | 362.87 Million USD | -137.661% |
| Korro Bio, Inc. | 84.53 Million USD | -920.186% |
| Kineta, Inc. | 21.15 Million USD | -3976.404% |
| BioVie Inc. | 31.95 Million USD | -2599.212% |
| Codexis, Inc. | 66.51 Million USD | -1196.497% |
| Celularity Inc. | 215.05 Million USD | -301.01% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -280.549% |
| Celcuity Inc. | 66.23 Million USD | -1202.128% |
| Virax Biolabs Group Limited | 6.54 Million USD | -13072.38% |
| Cibus, Inc. | 320.3 Million USD | -169.245% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1905.591% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -2448.174% |
| IN8bio, Inc. | 30.33 Million USD | -2742.746% |
| Kodiak Sciences Inc. | 277.32 Million USD | -210.977% |
| Annexon, Inc. | 143.72 Million USD | -500.046% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -575.913% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -3664.477% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -134650.625% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -10.623% |
| Eyenovia, Inc. | 25.4 Million USD | -3294.43% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -514.62% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -15405.286% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -989.816% |
| Arcellx, Inc. | 200.19 Million USD | -330.773% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1778.876% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -298.503% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -8561.284% |
| Moolec Science SA | 52.75 Million USD | -1534.87% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1310.586% |
| Geron Corporation | 70.44 Million USD | -1124.293% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1753.038% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -816.749% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -9145.459% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -3711.135% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -314.992% |
| Humacyte, Inc. | 23.49 Million USD | -3570.273% |
| Structure Therapeutics Inc. | 102.77 Million USD | -739.118% |
| 89bio, Inc. | 151.2 Million USD | -470.358% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -976.229% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -5831.252% |
| Genelux Corporation | 24.33 Million USD | -3443.883% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -2442.24% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -398.877% |
| Notable Labs, Ltd. | 14.77 Million USD | -5738.89% |
| Liquidia Corporation | 87.98 Million USD | -880.183% |
| Mustang Bio, Inc. | 48.5 Million USD | -1678.116% |
| Immunovant, Inc. | 282.7 Million USD | -205.05% |
| Quantum-Si incorporated | 111.65 Million USD | -672.355% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -3725.426% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -3955.128% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -745.395% |
| Acasti Pharma Inc. | 11.3 Million USD | -7531.218% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -3662.489% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -5296.987% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1752.959% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -75910.859% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -5328.705% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2857.794% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1983.907% |
| PepGen Inc. | 84.76 Million USD | -917.394% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2810.479% |
| United Therapeutics Corporation | 885.1 Million USD | 2.564% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -3666.45% |
| Solid Biosciences Inc. | 104.31 Million USD | -726.731% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -2535.263% |
| Immuneering Corporation | 58.41 Million USD | -1376.393% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -16842.319% |
| Silo Pharma, Inc. | 3.92 Million USD | -21889.691% |
| Belite Bio, Inc | 31.66 Million USD | -2623.266% |
| XOMA Corporation | 46.46 Million USD | -1756.109% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -1176.69% |
| Bionomics Limited | 17.89 Billion USD | 95.18% |
| Apogee Therapeutics, Inc. | 93 Million USD | -827.286% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2517.052% |
| uniQure N.V. | 285.08 Million USD | -202.507% |
| Cassava Sciences, Inc. | 105.95 Million USD | -713.919% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -11697.434% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -344.064% |
| Forte Biosciences, Inc. | 32.47 Million USD | -2555.43% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -10279.461% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2833.846% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -15405.286% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -5968.994% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -9601.924% |
| Altimmune, Inc. | 30.55 Million USD | -2722.372% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -101.661% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2517.052% |
| Compugen Ltd. | 43.97 Million USD | -1861.302% |
| Peak Bio, Inc. | 1249.13 USD | -69040272.099% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1063.524% |
| Benitec Biopharma Inc. | 22.38 Million USD | -3753.114% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -254.623% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -2921.42% |
| Zura Bio Limited | 62.63 Million USD | -1276.806% |
| PolyPid Ltd. | 21.04 Million USD | -3997.904% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -5198.624% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -2921.42% |
| Instil Bio, Inc. | 85.78 Million USD | -905.309% |
| argenx SE | 1.53 Billion USD | 43.763% |
| Immunome, Inc. | 122.82 Million USD | -602.169% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1679.143% |
| Verona Pharma plc | 67.15 Million USD | -1184.27% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -3231.675% |
| Shattuck Labs, Inc. | 93.61 Million USD | -821.234% |
| CervoMed Inc. | 14.95 Million USD | -5665.593% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -1119.756% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -9993.68% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1590.988% |
| Moolec Science SA | 52.75 Million USD | -1534.87% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -5143.075% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -550.6% |
| AnaptysBio, Inc. | 181.56 Million USD | -374.976% |
| Design Therapeutics, Inc. | 78.19 Million USD | -1002.959% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -890.802% |
| NeurAxis, Inc. | 8.82 Million USD | -9676.494% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -6752.634% |
| Lumos Pharma, Inc. | 38.66 Million USD | -2130.451% |
| Achilles Therapeutics plc | 75.25 Million USD | -1045.976% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -3231.675% |
| 180 Life Sciences Corp. | 13.47 Million USD | -6298.843% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -3154.055% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -29303.628% |
| Nutriband Inc. | 5.73 Million USD | -14940.1% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -678.483% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1449.609% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1595.01% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -1204.716% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1493.412% |
| Palisade Bio, Inc. | 13.32 Million USD | -6374.505% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1799.192% |
| Beam Therapeutics Inc. | 554.19 Million USD | -55.614% |
| Neurogene Inc. | 55.58 Million USD | -1451.561% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -247.059% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1680.759% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -791.742% |
| Sesen Bio, Inc. | 78.38 Million USD | -1000.272% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -932.461% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -6751.602% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -91.223% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -881.231% |
| Athira Pharma, Inc. | 125.46 Million USD | -587.361% |
| Vaccinex, Inc. | 23.45 Million USD | -3576.845% |
| HCW Biologics Inc. | 21.02 Million USD | -4001.311% |
| XOMA Corporation | 46.46 Million USD | -1756.109% |
| Nektar Therapeutics | 190.9 Million USD | -351.75% |
| Arvinas, Inc. | 480 Million USD | -79.668% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -37825.039% |
| Merus N.V. | 200.49 Million USD | -330.14% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -734.41% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -2391.057% |
| Rezolute, Inc. | 70.38 Million USD | -1125.232% |
| Clene Inc. | 41.07 Million USD | -1999.686% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -5165.472% |
| BeyondSpring Inc. | 24.86 Million USD | -3368.345% |
| Synlogic, Inc. | 58.53 Million USD | -1373.389% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -4720.054% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -19098.664% |
| Peak Bio, Inc. | 1249.13 USD | -69040272.099% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1326.735% |
| Krystal Biotech, Inc. | 160.42 Million USD | -437.571% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -218.664% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -147.79% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -39886.572% |
| MannKind Corporation | 125.59 Million USD | -586.644% |
| Ikena Oncology, Inc. | 84.57 Million USD | -919.667% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -8839.608% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -862.494% |
| Gossamer Bio, Inc. | 183.75 Million USD | -369.313% |
| CohBar, Inc. | 12.38 Million USD | -6861.441% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1600.189% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -3026.691% |
| Legend Biotech Corporation | 583.14 Million USD | -47.888% |
| Mural Oncology plc | 192.07 Million USD | -349.003% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -1184.352% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -5241.527% |
| Disc Medicine, Inc. | 91.12 Million USD | -846.397% |
| Champions Oncology, Inc. | 28.11 Million USD | -2967.962% |
| REGENXBIO Inc. | 321.15 Million USD | -168.53% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -15985.924% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1446.747% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -2113.526% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -654.133% |
| Vaxart, Inc. | 90.72 Million USD | -850.559% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -10022.103% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1915.241% |
| Cellectis S.A. | 97.32 Million USD | -786.153% |
| Longeveron Inc. | 21.25 Million USD | -3958.372% |
| Repare Therapeutics Inc. | 167.35 Million USD | -415.308% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 36.626% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1040.067% |
| Revolution Medicines, Inc. | 498.76 Million USD | -72.908% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -12864.582% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1862.06% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1056.193% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -1138.463% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -7697.505% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 81.939% |
| Denali Therapeutics Inc. | 527.23 Million USD | -63.573% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -9862.313% |
| Veru Inc. | 101.34 Million USD | -750.932% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -3584.385% |
| Cingulate Inc. | 22.75 Million USD | -3689.256% |
| Passage Bio, Inc. | 108.38 Million USD | -695.656% |
| Context Therapeutics Inc. | 25.07 Million USD | -3339.625% |
| Exicure, Inc. | 14.07 Million USD | -6026.769% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -318.513% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1891.649% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -9297.153% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -241.569% |
| Nuvalent, Inc. | 149.49 Million USD | -476.89% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -10590.647% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -732.035% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -3920.719% |
| OmniAb, Inc. | 83.89 Million USD | -927.956% |
| Anew Medical, Inc. | 1.3 Million USD | -66195.881% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -2532.169% |
| Lipocine Inc. | 15.08 Million USD | -5618.807% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -1158.745% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1032.477% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2039.201% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -650.942% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -3752.77% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -29.852% |
| Ocugen, Inc. | 71.56 Million USD | -1105.03% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -818.761% |
| Q32 Bio Inc. | 92.68 Million USD | -830.518% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -3972.939% |
| Alumis Inc. Common Stock | 158.17 Million USD | -445.225% |
| Equillium, Inc. | 50.6 Million USD | -1604.154% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -1281.925% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -6101.867% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -4471.424% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -1736.817% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -695.092% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -6858.953% |
| Dominari Holdings Inc. | 23.83 Million USD | -3518.225% |
| Edesa Biotech, Inc. | 9.22 Million USD | -9250.825% |
| vTv Therapeutics Inc. | 11.9 Million USD | -7142.832% |
| Bio-Techne Corporation | 563.03 Million USD | -53.169% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -110.957% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -220.887% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -551.968% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -5884.345% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -426.833% |
| Nkarta, Inc. | 131.65 Million USD | -555.073% |
| BioCardia, Inc. | 12.12 Million USD | -7014.958% |
| Iterum Therapeutics plc | 47.46 Million USD | -1716.811% |